Before You File the PDF: A Practical Analytical Report Audit

A readable PDF can still leave the central research question unanswered. Begin your review by identifying the issuing laboratory, report identifier, sample description, sample or lot mapping, issue date, and document version. Look for a clear indication that the report is final or authorized, and retain all pages rather than only the results panel.

Our suggested audit is a sequence of questions, not a universal mandatory COA template. Different analytical services provide different report formats. Record each missing item as a question to resolve in the context of the study. NIST's reference-material guidance provides a useful example of why matching a unit's identifier to its certificate comes before interpreting its values.

For each reported result, identify the measured property, unit, method reference, and any stated acceptance criterion. Distinguish a numerical observation from a pass designation. If the report lists only a pass, ask whether the actual measurement or relevant limit is available when the experiment requires it. Avoid comparing numbers that describe different properties.

A result's decimal places are not a substitute for method performance. ICH Q2(R2) distinguishes validation characteristics such as accuracy, precision, specificity, and range. This framework is useful background for asking a laboratory what supports a particular result. It does not mean that a short research COA must reproduce an entire validation package or that an unspecified method meets pharmaceutical validation expectations.

A chromatogram image summarizes a processed signal. FDA's records-and-reports discussion explains that a printed chromatogram does not generally contain the injection sequence, instrument method, integration method, or audit trail associated with the original electronic record. Those observations arise in drug-manufacturing oversight, but the distinction between a picture and its underlying data is useful for research interpretation too.

A buyer may reasonably receive a final analytical report rather than every instrument file. The practical question is whether the report gives enough information for the intended decision and whether the laboratory can clarify the underlying analysis when appropriate. A missing raw-data attachment is not, by itself, evidence that a report is false. Nor does a polished plot prove completeness.

If laboratory accreditation is relevant to the project, use the accrediting body's own directory and review the stated scope. Match the laboratory identity and location, then examine the methods or measurement categories covered. Save the scope version and the date checked. Do not assume a logo establishes coverage for every test a laboratory can offer.

NIST's NVLAP program assesses laboratories against ISO/IEC 17025 requirements and maintains laboratory and method information. Its reporting rules illustrate that accredited and non-accredited results can need explicit distinction. NVLAP is one example of an accreditation program, not a claim about any laboratory used by Pax Peptide. Ask which specific result is covered when the scope is unclear.

Write a short disposition: adequate for the planned document review, clarification requested, or insufficient for a specific study requirement. Name the requirement and the unresolved issue. This is more useful than awarding a generic quality score, because another project may need a different measurement or a more complete record from the same material.

Retain the original report, your review note, and any clarifications together. If an amended report arrives, link it to the earlier version and record the reason given. For Pax Peptide purchases, review the documents currently available for the intended product and lot; request clarification where needed. Document availability alone should not be read as a universal guarantee of testing scope or research suitability.